Author: Akan Oton, Catalent
Counterfeit drugs are an adverse symptom of the complexity of the pharmaceutical distribution network, demanding that manufacturers and other stakeholders drive toward implementing track-and-trace solutions to secure the global supply chain. The author, global marketing director at Catalent, discuss the pros and cons of various track-and-trace technologies and explores the larger global problem of the lack of safety regulations in foreign countries where counterfeit medication usually originates.